BackLiminatus Pharma Class A Common Stock Overview

Liminatus Pharma Class A Common Stock Common Stock

Liminatus Pharma Class A Common Stock's common stock is $5.6K.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$5597.00
↑ 115.19% YoYΔ $2996.00 vs prior year quarter

Peer trimmed avg / median

Loading

Liminatus Pharma Class A Common Stock Common Stock History

Loading

Liminatus Pharma Class A Common Stock vs. peers: Common Stock Comparison

Loading

Liminatus Pharma Class A Common Stock Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Liminatus Pharma Class A Common Stock (LIMN) FAQ

The latest common stock for LIMN is $5.6K as of June 2026. That compares with $2.6K in the prior-year period — up 115.2% year over year. Investors often review this figure alongside Liminatus Pharma Class A Common Stock's historical trend and sector peers before judging valuation or financial health.

Over the past year, LIMN's common stock moved from $2.6K to $5.6K — a 115.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Liminatus Pharma Class A Common Stock's operating scale or balance-sheet position.

A common stock figure of $5.6K for LIMN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LIMN's common stock ($5.6K), review year-over-year change from $2.6K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.